首页 社会正文

博彩【cai】平台【tai】大全(www.99cx.vip)_Demand recovery to boost IHH prospects

admin 社会 2022-06-24 04:58:49 2 0

博彩平台大全www.99cx.vip)是一个{ge}开放皇冠体{ti}育『yu』网「wang」址代理APP下(xia)载、皇「huang」冠 guan[体育网址会员 yuan[APP下载、皇冠体育网址线 xian[路APP下载、皇『huang』冠体《ti》育《yu》网址登(deng)录‘lu’APP下载《zai》的【de】官‘guan’方平台「tai」。博‘bo’彩平台大全上最新博彩平台登录线路、博彩平【ping】台{tai}代理网址更新最(zui)快。博『bo』彩平台(tai)大“da”全开放皇〖huang〗冠官方会“hui”员注册『ce』、皇冠官『guan』方代理《li》开户等【deng】业务 wu[。

,

KUALA LUMPUR: Kenanga Research is raising its earnings forecasts on IHH Healthcare Bhd as it expects demand recovery to accelerate following the end of the pandemic in its operating markets.

According to the research house, there have been strong returns of domestic patients and an increase in foreign patients in Malaysia and Singapore in April while high bed occupancy rates are expected to continue in Turkey and Europe.

It added that it the group expects gradual improvement of non-Covid patients in India starting from 2QFY22 as there was a depression on low elective surgeries in 1QFY22 due to the omicron wave.

On inflation pressure, Kenanga noted that IHH had adjusted prices for inflation in 1QFY22 but stopped short of guiding for further upwards price adjustment.

However, it added that medical supplies inflation which represents bulk of its cost is less than price inflation and hence, it enjoys the difference which flowthrough to margins.

"Given the low 'price elasticity of demand' of private healthcare services, IHH has been able to pass on cost inflation to customers, as reflected in its rising revenue per inpatient over the past several quarters.

"In tandem with the stronger-than-expected demand weexpect revenue per inpatient to surpass our earlier expectations," said Kenanga.

The research firm forecasts higher FY22 revenue per inpatient in Singapore, Malaysia and Acibadem of 18%, 11% and 20% respectively, up from 8%, 9% and 10%.

It raised its recommendation to "outperform" from "market perform" and its target price to RM7.20 from RM6.28 previously.


转载说明:本文‘wen’转载(zai)自Sunbet。
版权声明

本文仅代表作者观点,不代表本站立场。
本文系作者授权发表,未经许可,不得转载。

发表评论

评论列表(0人评论 , 2人围观)
☹还没有评论,来说两句吧...

热门标签

    此处不必修改,程序自动调用!